Cairo – Mubasher: Ibnsina Pharma reported net profits of EGP 50.37 million in the first quarter (Q1) of 2021, slightly up from EGP 50.27 million in the prior-year period.
The sales increased to EGP 4.75 billion in the January-March period, compared to EGP 4.44 billion in the corresponding period a year earlier, the company said in a bourse disclosure on Monday.
In 2020, Ibnsina Pharma recorded net profits of EGP 224.66 million, down from EGP 328.77 million a year earlier, including minority shareholders’ rights.
Source: Mubasher
All Rights Reserved - Mubasher Info © 2005 - 2021 Provided by SyndiGate Media Inc. (Syndigate.info).
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
